Open main menu

HemOnc.org - A Hematology Oncology Wiki β

Editorial Board

Our editorial board is comprised of clinical experts, organized primarily by disease focus. Most disease sites now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].

Contents

Editor-in-Chief

Peter C. Yang, MD
Boston, MA

 Hem_Onc
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts.

Deputy Editor

Jeremy L. Warner, MD, MS, FAMIA
Vanderbilt University
Nashville, TN

 Hemoncwarner
LinkedIn
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.

Section Editors

Breast Oncology
Hermina Fernandes, MD, FACP
Bismarck, ND
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the Edith Sanford Breast Center at Sanford Health. She is a clinical assistant professor at the University of North Dakota.
Dermatologic Oncology
Elizabeth Buchbinder, MD
Boston, MA

LinkedIn
Dr. Buchbinder is board certified in Medical Oncology; she practices at the Dana-Farber Cancer Institute. She is an instructor at Harvard Medical School.
Endocrine Oncology
Jeena M. Varghese, MBBS
Houston, TX

LinkedIn
Dr. Varghese is board certified in Internal Medicine and Endocrinology; she practices and is an assistant professor at the University of Texas MD Anderson Cancer Center.
Gastrointestinal Oncology
Neeta K. Venepalli, MD, MBA
Chicago, IL
Dr. Venepalli is board certified in Medical Oncology; she practices at UI Health. She is an associate professor at the University of Illinois at Chicago.
Genitourinary Oncology
Eddy J. Chen, MD
Boston, MA
Dr. Chen is board certified in Hematology and Medical Oncology; he practices at Massachusetts General Hospital. He is an instructor at Harvard Medical School.
Gynecologic Oncology
Summer B. Dewdney, MD
Chicago, IL
Dr. Dewdney is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at Rush Copley Medical Center. She is an assistant professor at Rush University.
Head & Neck Cancer
Michael Gibson, MD, PhD
Nashville, TN

 mgibson21212
LinkedIn
Dr. Gibson is board certified in Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.
Neuro-Oncology
Seema Nagpal, MD
Palo Alto, CA
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a clinical assistant professor at Stanford University
Sarcoma
James L. Chen, MD, MS
Columbus, OH

LinkedIn
Dr. Chen is board certified in Medical Oncology; he practices at an academically affiliated institution in the Columbus area.
Thoracic Oncology
Travis Osterman, DO, MS
Nashville, TN

 TravisOsterman
LinkedIn
Dr. Osterman is board certified in Medical Oncology and Clinical Informatics; he practices at Vanderbilt University Medical Center. He is an assistant professor at Vanderbilt University.
Acute Leukemias
Martin W. Schoen, MD, MPH
Saint Louis University
St. Louis, MO
Dr. Schoen is board certified in Internal Medicine; he is a senior hematology/oncology fellow at Saint Louis University.
Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Sanjay R. Mohan, MD, MSCI
Nashville, TN
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Aggressive Lymphomas
Jose C. Villasboas Bisneto, MD
Rochester, MN
Dr. Villasboas Bisneto is board certified in Hematology and Medical Oncology; he practices at the Mayo Clinic.
Indolent Lymphomas
Sanjai Sharma, MD
Visalia, CA
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center.
Plasma Cell Dyscrasias
Andrew J. Cowan, MD
Seattle, WA

 andrewcowanmd
LinkedIn
Dr. Cowan is board certified in Hematology and Medical Oncology; he practices at the Seattle Cancer Care Alliance. He is an assistant professor at the University of Washington.
T-cell and NK-cell neoplasms
Unfilled If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Lymphoproliferative disorders
Unfilled If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Histiocyte Disorders
Ronald S. Go, MD
Rochester, MN
Dr. Go is board certified in Hematology and Medical Oncology; he practices at the Mayo Clinic, where he is an associate professor.
Immuno-Oncology
Meghan J. Mooradian, MD
Boston, MA

LinkedIn
Dr. Mooradian is board certified in Medical Oncology; she practices at Massachusetts General Hospital. She is an instructor at Harvard Medical School.
Pediatric Oncology
Wayne H. Liang, MD, MS
Birmingham, AL

 WayneLiangMD
LinkedIn
Dr. Liang is board certified in Pediatrics and board eligible in Pediatric Hematology-Oncology; he practices at Children's of Alabama. He is an assistant professor at UAB.
Transplant
Aric C. Hall, MD
Madison, WI

 AricHall1
Dr. Hall is board certified in Hematology and Medical Oncology; he practices at UW Health. He is an assistant professor at the University of Wisconsin.
Classical Hematology
Shruti Chaturvedi, MBBS, MSCI
Baltimore, MD

LinkedIn
Dr. Chaturvedi is board certified in Hematology and Medical Oncology; she practices at Johns Hopkins Medicine. She is an assistant professor at Johns Hopkins University.
Benjamin Tillman, MD
Nashville, TN
Dr. Tillman is board certified in Internal Medicine and board eligible in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.

COI Disclosures

To be completed; please see our conflict of interest page for more details.

Name Research funding Other (honoraria, travel support, significant ownership interests, etc.) Date of disclosure
Dr. Liang Nothing to disclose Nothing to disclose Sept. 17, 2018
Dr. Tillman Nothing to disclose Nothing to disclose Sept. 13, 2018
Dr. Warner NIH; Vanderbilt University ASCO; HemOnc.org Sept. 17, 2018
Dr. Villasboas Bisneto DoD; Lymphoma Research Foundation Nothing to disclose Sept. 13, 2018
Dr. Yang Nothing to disclose HemOnc.org; stock: Merck, Pfizer Oct. 3, 2018